VIPR2 Antikörper (AA 95-123)
Kurzübersicht für VIPR2 Antikörper (AA 95-123) (ABIN2629839)
Target
Alle VIPR2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 95-123
-
Spezifität
- This VIPR2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 95-123 amino acids from the N-terminal region of human VIPR2.
-
Aufreinigung
- Affinity purified
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Approved: ELISA (1:1000), WB (1:100 - 1:500)
-
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- PBS, pH 7.2, 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- May be stored at 4°C for short-term only. Aliquot to avoid freeze-thaw cycles. Store at -20°C. Aliquots are stable for 1 year.
-
-
- VIPR2 (Vasoactive Intestinal Peptide Receptor 2 (VIPR2))
-
Andere Bezeichnung
- VPAC2 / VIPR2
-
Hintergrund
-
Name/Gene ID: VIPR2
Subfamily: Vasoactive intestinal polypeptide
Family: GPCR
Synonyms: VIPR2, C16DUPq36.3, DUP7q36.3, PACAP-R-3, Pvr3, Vip type-2 receptor, Vip-r2, Vip2 receptor, PACAP type III receptor, Pacap type-3, PACAP-R3, PACAPR-3, VIP and PACAP receptor 2, VIP-R-2, VIP2R, VPAC2, VPCAP2R, PACAP3, Vip2, VPAC2R -
Gen-ID
- 7434
-
Pathways
- cAMP Metabolic Process
Target
-